Terumo Says Year-Old U.S. Unit To Spend $6 Million Expanding Production
This article was originally published in PharmAsia News
Executive Summary
Japan's Terumo said its U.S. unit plans to expand its production capacity at a cost of $6 million to meet demand for its products, including blood-transfusion gear in which it is a global leader.